Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000588316 | SCV000694110 | likely benign | not specified | 2019-08-20 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000775347 | SCV000909626 | likely benign | Hereditary cancer-predisposing syndrome | 2017-11-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003767323 | SCV001021890 | likely benign | Familial adenomatous polyposis 1 | 2024-06-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000775347 | SCV001188446 | likely benign | Hereditary cancer-predisposing syndrome | 2019-07-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Myriad Genetics, |
RCV003767323 | SCV005084494 | benign | Familial adenomatous polyposis 1 | 2024-04-09 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |